Case Report: Diagnostic challenges in Fabry disease: misinterpreted obstructive hypertrophic cardiomyopathy and the role of enzyme replacement therapy
Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder. The abnormal accumulation of metabolic substrates induces inflammation and fibrosis in cells, resulting in organ dysfunction. The clinical manifestations of FD are diverse and non-specific. In the present study, we report a...
Saved in:
| Main Authors: | Weili Cheng, Mingqiang Ao, Dinghu Xu, Yuqing Zhang, Qin Tao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1479374/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study
by: Zongwei Lin, et al.
Published: (2024-12-01) -
Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation, and Down‐Regulation of Mannose‐6‐Phosphate Receptors Cause Low Accessibility to Enzyme Replacement Therapy
by: Andrea Frustaci, et al.
Published: (2025-02-01) -
Current status of the immunogenicity of enzyme replacement therapy in fabry disease
by: Jorge F. Gómez-Cerezo, et al.
Published: (2025-05-01) -
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
by: Malte Lenders, et al.
Published: (2025-02-01) -
Fabry Disease - literature review
by: Krystian Wdowiak, et al.
Published: (2024-11-01)